The economic burden of musculoskeletal disease in Korea: A cross sectional study

Table 3 Direct and indirect costs of musculoskeletal disease in Korea, 2008

		Direct costs								Indirect costs		Total costs^†
Age group	Population	Direct medical care costs					Direct non-medical care costs		Total direct costs
	(thousand persons)	Paid by insurer	Paid by patient	OTC drugs costs	Other costs	Total direct medical care costs^*	Transportation	Caregiver costs		Lost productivity	Cost of premature death
Male
0-19 years	6,168	17,954	39,549	47	97	57,647	506	2,901	61,054	0	640	61,694
20-64 years	16,216	443,446	361,346	2,092	4,760	811,644	11,144	66,877	889,666	753,139	31,248	1,674,052
≥65 years	2,032	368,355	169,309	2,099	1,879	541,643	7,518	43,610	592,771	0	0	592,771
Male Cost	24,416	829,756	570,204	4,239	6,736	1,410,934	19,169	113,388	1,543,491	753,139	31,888	2,328,517
Female
0-19 years	5,567	35,514	22,019	43	83	57,658	474	3,992	62,125	0	2,505	64,630
20-64 years	15,640	877,142	625,749	4,761	11,667	1,519,320	22,484	92,053	1,633,856	1,530,437	45,028	3,209,321
≥65 years	2,984	728,612	459,014	2,377	6,494	1,196,497	26,857	60,027	1,283,382	0	0	1,283,382
Female Cost	24,191	1,641,268	1,106,783	7,181	18,244	2,773,475	49,815	156,073	2,979,363	1,530,437	47,533	4,557,333
Total Cost	48,607	2,471,024	1,676,987	11,419	24,980	4,184,409	68,984	269,461	4,522,854	2,283,575	79,421	6,885,850

OTC drugs: Over the counter drugs, Unit: thousand dollars
*Sum of costs paid by insurer + costs paid by patients + OTC drugs costs+ other costs
^†Sum of direct costs + indirect costs.

ISSN: 1471-2474